Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
TNYA Tenaya Therapeutics Inc
- Stocks
- Healthcare
- NASDAQ: TNYA
Price (delayed)
$0.3944
Market cap
$64.16M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.15
Enterprise value
$23.29M
Highlights
The EPS has increased by 30% year-on-year and by 12% since the previous quarter
The net income is up by 15% year-on-year and by 4.8% since the previous quarter
The quick ratio has soared by 62% QoQ but it is down by 2.4% YoY
TNYA's equity is up by 29% from the previous quarter but it is down by 25% YoY
Key stats
What are the main financial stats of TNYA
Market
Valuations
Earnings
Shares outstanding
162.67M
Market cap
$64.16M
Enterprise value
$23.29M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.29
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$109.72M
Net income
-$105.77M
EBIT
-$105.77M
EBITDA
-$93.61M
Free cash flow
-$85.8M
Per share
Balance sheet
Liquidity
EPS
-$1.15
EPS diluted
-$1.15
Free cash flow per share
-$0.78
Book value per share
$1.36
Revenue per share
$0
TBVPS
$1.31
Total assets
$143.95M
Total liabilities
$24.56M
Debt
$12.91M
Equity
$119.4M
Working capital
$80.33M
Debt to equity
0.11
Current ratio
6.68
Quick ratio
6.23
Net debt/EBITDA
0.44
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-74.5%
Return on equity
-92.2%
Return on invested capital
-96.9%
Return on capital employed
-81.5%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TNYA stock price
How has the Tenaya Therapeutics stock price performed over time
Intraday
-4.06%
1 week
-15.49%
1 month
-19.98%
1 year
-90.79%
YTD
-72.42%
QTD
-30.82%
Financial performance
How have Tenaya Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$109.72M
Net income
-$105.77M
Gross margin
N/A
Net margin
N/A
The operating income has grown by 16% year-on-year and by 5% since the previous quarter
The net income is up by 15% year-on-year and by 4.8% since the previous quarter
Price vs fundamentals
How does TNYA's price correlate with its fundamentals
Growth
What is Tenaya Therapeutics's growth rate over time
Valuation
What is Tenaya Therapeutics stock price valuation
P/E
N/A
P/B
0.29
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has increased by 30% year-on-year and by 12% since the previous quarter
TNYA's P/B is 76% below its last 4 quarters average of 1.2
TNYA's equity is up by 29% from the previous quarter but it is down by 25% YoY
Efficiency
How efficient is Tenaya Therapeutics business performance
Tenaya Therapeutics's return on equity has decreased by 21% YoY and by 3.2% QoQ
The ROA has contracted by 15% YoY and by 2.1% from the previous quarter
TNYA's ROIC is up by 8% YoY
Dividends
What is TNYA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TNYA.
Financial health
How did Tenaya Therapeutics financials performed over time
The quick ratio has soared by 62% QoQ but it is down by 2.4% YoY
The current ratio has surged by 58% since the previous quarter
The debt is 89% smaller than the equity
TNYA's debt to equity has surged by 57% year-on-year but it is down by 27% since the previous quarter
TNYA's equity is up by 29% from the previous quarter but it is down by 25% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.